# Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic Approach

> **NCT07147751** · — · NOT_YET_RECRUITING · sponsor: **International Extranodal Lymphoma Study Group (IELSG)** · enrollment: 100 (estimated)

## Conditions studied

- Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07147751
- **Lead sponsor:** International Extranodal Lymphoma Study Group (IELSG)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2029-12
- **Final completion:** 2029-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07147751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07147751, "Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic Approach". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07147751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*